Hosted on MSN1mon
Pfizer going 'all in' on obesity drug development, CEO Bourla saysPfizer is testing a once-a-day form of its oral drug, danuglipron, and expects to offer patients a more convenient alternative to injections. Bourla said that the company could begin a late-stage ...
Rubio Warns That China Can ‘Shut Down’ Panama Canal: ‘Direct Threat’ Remember: The Government Doesn’t Have to Run Air Traffic Control RFK Jr. on the Hot Seat Pentagon Official Floats ...
The new vaccines form GSK and Pfizer are expected to be available this fall. Rochelle Walensky is leaving her job as director of the Centers for Disease Control and Prevention, the White House ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results